Serum Heparanase: A New Clinical Biomarker Involved in Senile Metabolic Inflammatory Syndrome

Qingsong Wang; Xiu-Ling Zhou; Guang-Hai Mei; Jiantao Wang; Zhongyu Yu; Yue Hu; Xinyu Guo; Hanyu Zhang; Xiaodie Xu; Chengfeng He; Jingchun Guo; Yinghong Tao; Houguang Zhou

doi:10.2147/DMSO.S291612

Serum Heparanase: A New Clinical Biomarker Involved in Senile Metabolic Inflammatory Syndrome

Diabetes Metab Syndr Obes. 2021 Jul 13:14:3221-3228. doi: 10.2147/DMSO.S291612. eCollection 2021.

Authors

Qingsong Wang¹, Xiu-Ling Zhou², Guang-Hai Mei³, Jiantao Wang¹, Zhongyu Yu¹, Yue Hu¹, Xinyu Guo¹, Hanyu Zhang¹, Xiaodie Xu⁴, Chengfeng He⁴, Jingchun Guo⁴, Yinghong Tao⁵, Houguang Zhou¹

Affiliations

¹ Department of Geriatrics, Huashan Hospital, National Clinical Research Center for Aging and Medicine, Fudan University, Shanghai, 200040, People's Republic of China.
² Department of Ultrasonics, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
³ Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
⁴ National Key Laboratory of Medical Neurobiology, Institute of Brain Science, Fudan University, Shanghai, 200030, People's Republic of China.
⁵ Department of Medical Examination Center, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China.

Abstract

Aim: Metabolic inflammation syndrome (MIS) can lead to a series of complications, but its exact inflammatory mechanism is still unclear. The aim of this study was to explore the correlation between heparanase (HPA) and MIS, and the close relationship between HPA and other chronic low-grade inflammation index, such as C-reactive protein (CRP) and interleukin-6 (IL-6).

Methods: A total of 105 patients with MIS in the physical examination population of Huashan Hospital affiliated to Fudan University from May to June 2018 were selected as the MIS group, and 52 patients who were relatively healthy during the same period were used as the control group. The basic clinical data of the selected candidates were collected, the levels of serum HPA, CRP and IL-6 were measured by ELISA, and the levels of blood glucose and blood lipids were also detected.

Results: Compared with the control group, the levels of HPA, CRP, IL-6, FBG, HbA_1C, and TG of MIS group were all significantly elevated (all P<0.05), and HDL-C levels were considerably reduced (P<0.05). Correlation analysis showed that there was a noticeably positive correlation between serum HPA level and CRP, IL-6 levels (P<0.05).

Conclusion: Higher HPA levels might play a certain role in the occurrence and development of MIS. There was a certain close correlation between serum HPA level and CRP and IL-6 levels, and which indicated that HPA was involved in the chronic low-grade inflammatory reaction process of MIS.

Keywords: C-reactive protein; CLGI; CRP; HPA; IL-6; MIS; chronic low-grade inflammation; heparanase; interleukin-6; metabolic inflammatory syndrome.